Rigel Pharmaceuticals
RIGL
#6528
Rank
A$1.10 B
Marketcap
A$61.05
Share price
-8.22%
Change (1 day)
131.24%
Change (1 year)

Market capitalization of Rigel Pharmaceuticals (RIGL)

Market cap: A$1.10 Billion

As of January 2026 Rigel Pharmaceuticals has a market cap of A$1.10 Billion. This makes Rigel Pharmaceuticals the world's 6528th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Rigel Pharmaceuticals from 2000 to 2026

End of year Market Cap

Year Marketcap Change
2026A$1.10 B-7.08%
2025A$1.19 B155.23%
2024A$0.46 B25.91%
2023A$0.37 B-2.59%
2022A$0.38 B-39.05%
2021A$0.62 B-18.73%
2020A$0.76 B49.8%
2019A$0.51 B-5.92%
2018A$0.54 B-25.03%
2017A$0.72 B122.87%
2016A$0.32 B-13.27%
2015A$0.37 B54.23%
2014A$0.24 B-12.68%
2013A$0.27 B-48.69%
2012A$0.54 B-0.58%
2011A$0.54 B41.48%
2010A$0.38 B-29.55%
2009A$0.55 B32.59%
2008A$0.41 B-54.48%
2007A$0.91 B140.36%
2006A$0.37 B33.74%
2005A$0.28 B-54.3%
2004A$0.62 B61.98%
2003A$0.38 B328.87%
2002A$89.31 M-74.02%
2001A$0.34 B-47.77%
2000A$0.65 B

End of Day market cap according to different sources

On Jan 10th, 2026 the market cap of Rigel Pharmaceuticals was reported to be:

A$1.10 Billion
by Nasdaq info icon info icon
A$1.10 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
ChemoCentryx
CCXI
A$5.58 B 404.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
A$0.22 B-79.89%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
A$438.70 B 39,488.33%๐Ÿ‡ฌ๐Ÿ‡ง UK
Amgen
AMGN
A$262.50 B 23,587.89%๐Ÿ‡บ๐Ÿ‡ธ USA